Takeda and Orexigen Launch Weight Management Drug Contrave in U.S.

Takeda Pharmaceutical and Orexigen Therapeutics have launched Contrave (naltrexone HCI and bupropion HCI) extended-release tablets in the U.S. and will be available to patients by prescription.
Pharmaceutical Business Review